GO
Loading...

Salix Pharmaceuticals Ltd

More

  • *October payrolls well above expectations. NEW YORK, Nov 8- U.S. stocks rose on Friday, rebounding from the previous session's selloff, after an unexpectedly strong payrolls report lent weight to views the world's largest economy is stronger than previously thought.

  • *Santarus jumps on buyout deal, acquirer Salix also up. NEW YORK, Nov 8- U.S. stocks rose on Friday, rebounding from the previous session's selloff, after an unexpectedly strong payrolls report lent weight to views the world's largest economy is stronger than previously thought.

  • *Santarus jumps on buyout deal, acquirer Salix also up. NEW YORK, Nov 8- U.S. stocks jumped on Friday, bouncing back from a selloff in the previous session after an unexpectedly strong payrolls report lent weight to views the world's largest economy is stronger than previously thought.

  • *Santarus jumps on buyout deal, acquirer Salix also up. NEW YORK, Nov 8- U.S. stocks jumped on Friday, bouncing back from a selloff in the previous session after an unexpectedly strong payrolls report lent weight to views the world's largest economy is stronger than previously thought.

  • *Santarus jumps on buyout deal. NEW YORK, Nov 8- U.S. stocks rose on Friday, shaking off the initial selloff in futures after an unexpectedly strong payrolls report increased chances the Federal Reserve could begin to scale back its stimulus before the end of the year.

  • US STOCKS-Wall St to open lower after payrolls data Friday, 8 Nov 2013 | 9:08 AM ET

    *Santarus jumps on buyout deal. NEW YORK, Nov 8- U.S. stocks were set for a lower open on Friday, after an unexpectedly strong payrolls report increased the possibility the Federal Reserve could begin to scale back its stimulus before the end of the year.

  • *Santarus jumps on buyout deal. NEW YORK, Nov 8- U.S. stock index futures edged higher on Friday, indicating the S&P 500 will bounce from its biggest daily decline since late August, ahead of a key report on the labor market.

  • *Santarus jumps on buyout deal. NEW YORK, Nov 8- U.S. stock index futures advanced on Friday, indicating the S&P 500 will rebound from its biggest daily decline since late August, ahead of a key report on the labor market.

  • *Offer of $32/ share is 37 pct above Santarus' Thursday close. Nov 7- Salix Pharmaceuticals Ltd will buy Santarus Inc for about $2.6 billion, gaining two new gastroenterology drugs to strengthen its leading presence in that market and sending its shares 10 percent higher.

  • UPDATE 1-Salix Pharma to buy Santarus for $2.6 billion Thursday, 7 Nov 2013 | 6:44 PM ET

    *Offer price of $32/ share is 37 pct above Santarus' Thursday close. Nov 7- Salix Pharmaceuticals Ltd will buy Santarus Inc for about $2.6 billion to boost its portfolio of drugs with a complementary set of products from the specialty pharmaceutical company. The $32 per share offer is a 37 percent premium to Santarus' Thursday close on the Nasdaq.

  • Salix Pharma agrees to buy Santarus for about $2.6 bln Thursday, 7 Nov 2013 | 4:23 PM ET

    Nov 7- Salix Pharmaceuticals Ltd said it has agreed to buy Santarus Inc for about $2.6 billion to acquire the specialty biopharmaceutical company's portfolio of gastrointestinal drugs. The $32 per share offer price is a 37 percent premium to Santarus' Thursday close of $23.22 on the Nasdaq.

  • Web Extra: Burned by Salix Pharma Tuesday, 22 Mar 2011 | 6:03 PM ET

    A long position in Salix Pharma looked like a hot trade but all it did was burn Joe Terranova. So what does he have to say about this stock now?

  • Small Caps vs Large Caps—Where to Invest Now Monday, 26 Apr 2010 | 4:03 PM ET

    With small-cap stocks thus far outperforming their large-cap counterparts through the recovery, do companies with smaller market share still have room to the upside? Bill McVail, lead manager of Turner Small Cap Growth Fund, and Kent Croft, chief investment officer of Croft Funds, offered their views and stock picks to CNBC.

  • Cramer makes the call on viewers' favorite stocks.

  • Stocks Gain Amid China M&A Buzz; GE Rallies Monday, 14 Sep 2009 | 5:26 PM ET

    Stocks moved into positive territory Monday afternoon as tech, bank and drug stocks gained and volatility waned.

  • Stocks Unfazed by Obama; Sprint Soars Monday, 14 Sep 2009 | 2:02 PM ET

    Stocks pared their losses Monday as President Obama's speech on financial reform had little impact on the market.

  • Stocks Slide as China Rift Rattles Market Monday, 14 Sep 2009 | 10:29 AM ET

    Stocks declined Monday as investors worried about a trade dispute between the US and China and reflected on the one-year anniversary of the Lehman Brothers collapse.

  • Futures Fall on China Rift; Lehman Recalled Monday, 14 Sep 2009 | 7:34 AM ET

    Investors were in a reflective mood Monday as the anniversary of the collapse of Wall Street titan Lehman Brothers brought back memories of the financial crisis and raised fresh doubts over the recovery.

  • Leaderboard: Top Two The Same-Taft Makes A Move Wednesday, 11 Apr 2007 | 8:57 AM ET

    Good morning all. Parker Robinson and James Kraber remain in the top two positions, with James holding the 2nd and 4th positions, and remember Deborah Taft? She made a strong move back into third place. Parker's portfolio value stands at $2,796,103.27, up $3,000 from Monday on bonus bucks.

Most Popular Video

Wednesday, 16 Apr 2014 | 4:03 PM ET

Providing instant analysis to Google's quarterly numbers, with Victor Anthony, Topeka Capital Markets; Andrew Stoltmann of Stoltmann Law Offices; CNBC contributor Michael Yoshikami; "Fast Money" trader Tim Seymour; CNBC's Michelle Caruso-Cabrera and Dominic Chu.

Wednesday, 16 Apr 2014 | 12:35 PM ET

Intel CEO Brian Krzanich discusses some signs of stability in enterprise in the mature markets, and whether the emerging markets area steadying as well.

Wednesday, 16 Apr 2014 | 11:56 AM ET

Art Cashin, UBS director of floor operations, explains what played into yesterday's market reversal and tells what sectors are back in favor today.